Albiglutide
A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.
GSK · Phase 3 · Completed · Enrollment 507
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| albiglutide | T2D only | n/r | n/r | n/r | n/r |
| sitagliptin | T2D only | n/r | n/r | n/r | n/r |